Ads
related to: Pfizer
Search results
A Struggling Pfizer Looks for Help From a Wall Streeter
Barrons.com· 7 hours agoAs the big drugmaker tries to turn its fortunes around by focusing on oncology, it has turned to a...
Decoding Pfizer Inc (PFE): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 1 day agoStrengths highlight Pfizer's robust product portfolio and global market presence. Weaknesses underscore the challenges in revenue fluctuations and patent...
Top Stock Reports for Amazon.com, Visa & Pfizer
Zacks via Yahoo Finance· 9 hours agoToday's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Visa Inc. (V) and Pfizer Inc. (PFE). These...
Pfizer agrees to settle 10K Zantac lawsuits, as GSK trial links heartburn drug to cancer
BenefitsPRO· 2 days agoPfizer has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its...
Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Zacks via Yahoo Finance· 16 hours agoPfizer (PFE) reports the death of a participant in a mid-stage study of its Duchenne drug. An FDA...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 2 weeks agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
Pfizer First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 4 days agoPfizer (NYSE:PFE) First Quarter 2024 Results Key Financial Results Revenue: US$14.9b (down 19% from...
Pfizer agrees to settle over 10,000 Zantac lawsuits, Bloomberg News reports
KFGO· 3 days ago(Reuters) -Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the...
Pfizer agrees to settle over 10K lawsuits linking Zantac to cancer
New York Post· 3 days agoPfizer has agreed to settle more than 10,000 lawsuits which alleged that the company failed to warn...
2 Beaten-Down Stocks to Buy and Hold for 10 Years
Motley Fool via Yahoo Finance· 17 hours agoSome corporations are condemned to deliver subpar financial results and stock market performances practically in perpetuity. Thankfully, Bristol Myers...
